Skip to content

Preoperative Prediction of Post-Hepatectomy Liver Failure Using a Multimodal Fusion-Based Future Liver Remnant Model

Preoperative Prediction of Post-Hepatectomy Liver Failure Using a Multimodal Fusion-Based Future Liver Remnant Model

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500105649
Enrollment
Unknown
Registered
2025-07-08
Start date
2025-07-14
Completion date
Unknown
Last updated
2025-07-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Post-hepatectomy liver failure

Interventions

Gold Standard:This project utilizes the "ISGLS criteria" as the diagnostic and grading standards for postoperative liver failure. The diagnostic criteria consist of abnormally elevated prothrombin tim
Index test:Prediction results of post-hepatectomy liver failure based on multimodal fusion

Sponsors

Peking University Shenzhen Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1.Voluntary participation, demonstrating good compliance, and willingness to cooperate with follow-up procedures. 2.Age: Participants must be at least 18 years of age and not older than 80 years. 3.The liver mass was comfirmed through imaging examinations, and hepatectomy was subsequently performed. 4.All patients received both contrast-enhanced abdominal CT scans and Gd-EOB-DTPA-enhanced MRI scans prior to surgery, with all imaging performed within three months of the operative date. 5.There was complete biochemical and clinical information available within two weeks prior to surgery, including informations of age, sex/gender, history of diabetes, surgical records, serum creatinine, urea, total serum bilirubin, and the international normalized ratio (INR) of prothrombin time. 6.From the 5th to the 30th day post-operation, INR and total serum bilirubin levels were monitored to assess the occurrence of postoperative liver failure.

Exclusion criteria

Exclusion criteria: 1.Noticeable artifacts were observed in the enhanced CT and/or MR images of the liver. 2.Imaging sequences were missing from the enhanced CT and/or MR examinations. 3.The clinical history was incomplete, and laboratory test results were unavailable. 4.Prior administration of anti-tumor treatments before surgery, including transarterial chemoembolization and systemic chemotherapy. 5.History of associating  liver partition and portal vein ligation for staged hepatectomy (ALPPS).

Design outcomes

Primary

MeasureTime frame
Incidence of post-hepatectomy liver failure within 30 days;

Countries

China

Contacts

Public ContactTingting Xie

Peking University Shenzhen Hospital

ttxietina@163.com+86 13410257730

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026